bioRxiv/medRxiv TRiP Review Activity

8,134 Reviews — eLife — All Subjects

Most recent first Previous |  Page 521: Articles 5201-5210  | Next

Constitutive Activation and Oncogenicity Are Mediated by Loss of Helical Structure at the Cytosolic Boundary of the Thrombopoietin Receptor
Defour, J.-P., Leroy, E., Dass, S., Balligand, T., Levy, G., Mouton, C., Genet, L., Pecquet, C., Smith, S. O., Constantinescu, S.
10.1101/2022.06.30.498238 — Posted: 2022-06-30 — Discussion: 2023-01-02  eLife
Csf1 from marrow adipogenic precursors is required for osteoclast formation and hematopoiesis in bone
Zhong, L., Lu, J., Fang, J., Yao, L., Yu, W., Gui, T., Holdreith, N., Bautista, C., Choi, Y., Jiang, J. X., Yang, S., Tong, W., Dyment, N., Qin, L.
10.1101/2022.07.27.501742 — Posted: 2022-07-29 — Discussion: 2023-01-02  eLife
Voltage clamp fluorometry analysis of the P2X7 receptor suggests a limited conformational interplay between extracellular ATP binding and the intracellular ballast domain
Durner, A., Durner, E., Nicke, A.
10.1101/2022.08.31.506013 — Posted: 2022-09-01 — Discussion: 2023-01-02  eLife
The Slingshot phosphatase 2 is required for acrosome biogenesis during spermatogenesis in mice
Xu, K., Su, X., Fang, K., Lv, Y., Lu, G., Chan, W., Chen, Z.-J., Ma, J., Liu, H.
10.1101/2022.09.15.508144 — Posted: 2022-09-17 — Discussion: 2023-01-02  eLife
A Process Model Account of the Role of Dopamine in Intertemporal Choice
Soutschek, A., Tobler, P. N.
10.1101/2022.10.24.513522 — Posted: 2022-10-25 — Discussion: 2023-01-02  eLife
Dalpiciclib Partially Abrogates ER Signaling Activation Induced by Pyrotinib In HER2+HR+ Breast Cancer
Liu, C., Bu, J., Zhang, Y., Niu, N., Bi, K., Sun, L., Qiao, X., Wang, Y., Zhang, Y., Jiang, X., Wang, D., Ma, Q., Li, H.
10.1101/2022.12.07.519433 — Posted: 2022-12-11 — Discussion: 2023-01-02  eLife
Reducing societal impacts of SARS-CoV-2 interventions through subnational implementation
Dekker, M. M., Coffeng, L. E., Pijpers, F. P., Panja, D., de Vlas, S. J.
10.1101/2022.03.31.22273222 — Posted: 2022-03-31 — Discussion: 2023-01-02  eLife
The impact of the Covid-19 pandemic on Italian population-based cancer screening activities and test coverage: results from national cross-sectional repeated surveys
Giorgi Rossi, P., Carrozzi, G., Falini, P., Sampaolo, L., Gorini, G., Zorzi, M., Armaroli, P., Senore, C., Sassoli de Bianchi, P., Masocco, M., Zappa, M., Battisti, F., Mantellini, P.
10.1101/2022.08.15.22278787 — Posted: 2022-08-17 — Discussion: 2023-01-02  eLife
Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
Lauer, R. C., Barry, M., Smith, T. L., Thomas, A., Wu, J., Du, R., Lee, J.-H., Rao, A., Dobroff, A. S., Arap, M. A., Nunes, D., Silva, I. T., Dias-Neto, E., Chen, I., McCance, D. J., Cavenee, W. K., Pasqualini, R., Arap, W.
10.1101/2022.10.25.22281522 — Posted: 2022-10-30 — Discussion: 2023-01-02  eLife
Elys deficiency constrains Kras-driven tumour burden by amplifying oncogenic stress
Morgan, K. J., Doggett, K., Geng, F.-S., Whitehead, L., Smith, K. A., Hogan, B. M., Simons, C., Baillie, G. J., Molania, R., Papenfuss, A. T., Hall, T. E., Ober, E. A., Stainier, D. Y. R., Gong, Z., Heath, J. K.
10.1101/2021.08.25.457580 — Posted: 2021-08-27 — Discussion: 2022-12-30  eLife

Evaluation Sources